About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, March 28th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

SEFE Inc. (SEFE)

Nebula Stocks reported previously on SEFE Inc. (SEFE) and today we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.

SEFE, Inc. is a development stage company whose shares trade on the OTC Bulletin Board. SEFE was founded to develop and bring to market technology that harnesses a renewable source of energy that naturally occurs in the atmosphere. Founded in 2004, the Company was formerly known as Midnight Candle Company. They changed their name to SEFE, Inc. in August 2010. SEFE has their headquarters in Tempe, Arizona.

The goal of the Company is to use their proprietary methodologies and inventions to capture and convert naturally occurring atmospheric static electric energy to usable energy. SEFE's energy production methodologies and technologies are not intrusive to existing communities. They are easily adoptable, provide high output, and leave a small carbon footprint.

The design of the SEFE Harmony system is to operate by capturing static electricity from the atmosphere and making it usable for utility companies; mining, construction, or other site-specific industrial concerns; relief organizations; among others. The Company's technology has undergone testing. It captures a renewable source. The technology is also one that is non-polluting, efficient, as well as economical.

Through a series of patent-pending devices, the Company can draw the static electricity in direct current form from the atmosphere, converting it to alternating current for immediate power consumption. The system could reconvert the alternating current back into direct current form for longer-term storage in banks of batteries. SEFE plans to generate revenue by selling the electricity produced by their Harmony III commercial grade units. The key to their Harmony III unit is its ability to capture and translate the electrical source found in the atmosphere into a usable current that can be utilized in generators and existing power grids without changes to the current power infrastructure.

SEFE has one issued patent, three allowed by the United States Patent and Trademark Office (USPTO) awaiting patent numbers, and 19 more at various stages of the filing process. The Company's patents will provide barriers to entry and fortify SEFE's foundational business construct. Furthermore, the Company will continue their forward-looking strategy resulting in additional patent filings and applications with the USPTO with the objective of protecting their inventions through the development of their business model.

The Company is focusing their efforts on commercial applications. They are also targeting world relief organizations, which often distribute aid and emergency relief in very remote parts of the world lacking electricity; and the military, which needs electrical generation at forward or temporary bases.

We have SEFE Inc. (SEFE) locked on our radar screens as "One to Watch" here at the QualityStocks Daily Newsletter.

SEFE Inc. (SEFE) closed on Wednesday at $0.93, up 6.80%, on 3,092,511 volume with 585 trades. The average volume for the last 60 days is 86,536. The 52-week low/high is $0.32/$1.35.

Bond Laboratories, Inc. (BNLB)

FeedBlitz reported previously on Bond Laboratories, Inc. (BNLB), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Bond Laboratories, Inc. is a manufacturer of innovative and proprietary nutritional supplements. The Company produces and markets products via their wholly owned operating division, NDS Nutrition Products (NDS), a national provider of innovative and proprietary nutritional supplements for health conscious consumers. NDS' products number more than 50 brands of energy, sports, and dietary supplements. Bond Laboratories has their headquarters in Omaha, Nebraska.

A team of highly experienced sales and marketing executives leads Bond Laboratories operating divisions. This team has significant expertise in the development, launch, and distribution of branded products in the nutritional supplement arena. The Company's products sell directly through specialty health and nutrition retailers. These products are included among the top-selling products at GNC® franchises. Bond Laboratories currently markets products to GNC franchise locations nationwide. The Company continually looks to increase the number of stores and number of approved products that comprise their distribution footprint.

Bond Laboratories' product lines include weight loss products, and NDS' PMD® (Professional Muscular Development) sports nutrition line. Their products also include Dr. Cholesterol, Dr. Detox, Dr. Essentials, Dr. Joints, and Dr. Joints Advanced. They also have their Core Active Nutrition line. Core Active Nutrition is a line of high quality, innovative, diet, health, and sports nutrition supplements.

In November 2011, the Company, through NDS Nutrition Products (NDS), introduced another new product for the GNC® franchise system. LipoRUSH is the newest entry into NDS' line of thermogenic weight-loss products. NDS products are presently available through approximately 800 GNC franchise locations across the country, an increase of 150 percent since January 2010.

Last week, Bond Laboratories announced that due to their sales success and customer popularity the Company is expanding upon their newly introduced Cardio Cuts® pre-workout drink. Cardio Cuts® is a creatine free, thermogenic, pre-workout drink. NDS has introduced two new flavors to add to their top selling Strawberry. Cardio Cuts® is now available in Black Cherry and Green Apple.

Bond Laboratories, Inc. (BNLB) closed on Wednesday at $0.09, up 2.81%, on 31,508 volume with 8 trades. The average volume for the last 60 days is 48,619. The 52-week low/high is $0.06/$0.16.

Reflect Scientific, Inc. (RSCF)

Emerging Markets reported previously onReflect Scientific, Inc. (RSCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Reflect Scientific, Inc. is a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries. Based in Orem, Utah, the Company develops and markets innovative, proprietary technologies in cryogenic cooling. Examples of Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. Reflect Scientific lists on the OTC Bulletin Board.

The Company's products include Cryometrix ultra low temperature freezers used to store blood, vaccines, DNA, RNA, proteins, and various other biological and chemical samples. Their products also include optically based chemical detection instruments for the analysis of whole blood for metabolic diseases, as well as other laboratory consumables and disposables. Cryometrix cooling and refrigeration products use an innovative liquid nitrogen technology. There are no compressors, no CFC's; there is low energy usage and greatly reduced maintenance.

Reflect Scientific's Visacon brand is about providing the highest quality original equipment manufacturer (OEM) products for chromatography. Products range from laboratory consumables to UV/VIS instrumentation. Visacon has 17 years of providing chromatography products to the life sciences markets. Custom manufacturing and packaging are their specialty.

Reflect Scientific's focus over the coming months will be on the commercialization of products acquired and developed over the last several years. The continued development and commercialization of the Company's ultra low temperature refrigerator line, with the refrigerated trailer, known as a "reefer", is being given highest priority.

Moreover, they will continue to develop and expand their focus on solutions to retrofit server and computer rooms to reduce the cost of cooling such rooms. They also continue to focus on the expansion of their detector line and contract manufacturing operations.

Reflect Scientific Management's focus over the last several years was on the acquisition and development of the Company's product lines. Management now believes the desired core product lines are in place. They will focus their efforts over the coming months on the commercialization of those product lines, marketing the products and expanding their customer base. Management will consider potential acquisitions that will complement or supplement their core technologies.

Reflect Scientific, Inc. (RSCF) closed on Wednesday at $0.08, up 14.29%, on 11,300 volume with 3 trades. The average volume for the last 60 days is 6,480. The 52-week low/high is $0.06/$0.19.

Craig Wireless Systems Ltd. (CWG.TO)

Today we are highlighting Craig Wireless Systems Ltd. (CWG.TO), closed on Wednesday at $0.28, down 1.72%, on 6,500 volume. The 52-week low/high is $0.11/$0.41.

Craig Wireless Systems Ltd. and their affiliates (collectively, the CWS Group) offer a wide spectrum of telecommunications services. These include broadband internet access, business connectivity solutions, hosting, and security and telecommunications solutions. The CWS Group acquires, cultivates and materializes frequency licenses into buildable opportunities for next generation communications networks. Craig Wireless Systems has their corporate headquarters in Rancho Mirage, California.

The Company was founded as Craig Media in the late 1940's. Their first spectrum and operations were in television and radio. The Company has since evolved to become Craig Wireless Systems and they continue the legacy by positioning themselves as a pioneer in spectrum development.

Through certain members of the CWS Group, Craig Wireless holds or leases licenses for spectrum in the 2.5 GHz, 2.6 GHz or 3.5 GHz bands in Riverside County in Southern California, United States and in Greece. The CWS Group also has spectrum interests in Norway and New Zealand.

Spectrum in these ranges is effective for delivery of point-to-multipoint signals, possesses robust bandwidth capability and supports emerging 4G-based services and applications, including portable and mobile applications. Spectrum held by Craig Wireless is technology neutral. It offers premier flexibility to launch whichever technology best suits the market needs (i.e. WiMAX (or Worldwide Interoperability for Microwave Access) and LTE (or Long Term Evolution)).

On November 30, 2011, Craig Wireless Systems completed the acquisition of the net assets of Woosh Wireless Ltd., a New Zealand wireless Internet company.  The Company now owns 51 percent of Woosh Wireless Holdings Ltd., which in turn holds 100 percent of the shares of Woosh Wireless (NZ) Ltd., the company that now owns the assets and conducts the business formerly carried on by Woosh Wireless.

Last week, Craig Wireless Systems announced that Mr. Murray Bamforth, Interim Chief Financial Officer has been appointed as Chief Financial Officer of the Company, and Mr. Gary Birkland, Director of Operations of the Company, has been appointed as Vice President of Operations of the Company. Both appointments are effective immediately.

Mr. Bamforth has more than 30 years of experience as a senior financial executive, CFO and external auditor and holds a Chartered Accountant designation. Mr. Birkland has extensive experience in the telecommunications industry including employment for over 35 years with Motorola, Inc. in varying positions culminating with Director of Operations.

Craig Wireless Systems Ltd. (CWG.TO) closed on Wednesday at $0.28, down 1.72%, on 6,500 volume. The 52-week low/high is $0.11/$0.41.

Laredo Oil, Inc. (LRDC)

We are highlighting Laredo Oil, Inc. (LRDC) today, here at the QualityStocks Daily Newsletter.

Laredo Oil, Inc. is a management services company managing the acquisition of mature oil fields and the recovery of stranded oil from those fields using Enhanced Oil Recovery (EOR) methods for their sole customer, Stranded Oil Resources Corp. (SORC). In June 2011, Laredo Oil announced that they entered into several agreements with SORC; an indirect, wholly owned subsidiary of Alleghany Corp. Laredo Oil is based in Austin, Texas.  

Laredo Oil's intention is to use an EOR method entitled Underground Gravity Drainage (UGD). The Company believes that the costs of implementing the UGD method are significantly lower than those currently experienced by commonly used EOR methods. In addition, they estimate that they can materially increase the field oil production rate from previous periods and recover amounts of oil equal to or greater than amounts previously recovered from the mature fields selected.

The agreements are to seek recovery of stranded crude oil from mature, declining oil fields by using the aforementioned Enhanced Oil Recovery (EOR) method known as Underground Gravity Drainage (UGD). The Company intends to pursue and recover stranded oil from selected mature fields chosen from this group, which SORC may acquire in their sole and absolute discretion. States containing within their boundaries oil fields which are initially being considered for acquisition by SORC include, but are not limited to, New Mexico, West Virginia, Mississippi, Texas, Oklahoma, Arkansas, and Montana.

The UGD method uses conventional mining processes to establish a chamber underneath an existing oil field. From this chamber, closely spaced wellbores can be drilled up into the reservoir, using gravity to drain the targeted reservoir through the wellbores. This method is applicable to mature oil fields that have very specific geological characteristics.

Laredo Oil has conducted extensive research; the Company has identified approximately 100 oil fields within the U.S. qualified for UGD recovery methods based upon the knowledge and expertise pertaining to the oil reservoir characteristics required before the UGD process can undergo successful implementation. Those characteristics include engineering parameters such as depth, field porosity, permeability, oil viscosity, temperature, and more. Those characteristics also include economic parameters such as field accessibility, business climate, and more.

Laredo Oil, Inc. (LRDC) closed on Wednesday at $0.22, even with yesterday’s close, on 19,940 volume with 6 trades. The average volume for the last 60 days is 37,721. The 52-week low/high is $0.05/$1.90.

Astrotech Corp. (ASTC)

CRWEFinance, DrStockPick, PennyToBuck, CRWEPicks, CRWEWallStreet, BestOtc, StockHotTips, and PennyOmega reported this month on Astrotech Corp. (ASTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Astrotech Corp. is one of the first space commerce companies and operates in the aerospace industry. The Company is a leader in identifying, developing and marketing space technology for commercial use. Astrotech provides spacecraft payload processing and government services, designs and manufactures space hardware, and commercializes space technologies for Earth based applications. The Company has their corporate headquarters in Austin, Texas.

Their Astrotech Space Operations business unit serves their government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. Astrotech's 1st Detect Corp. is developing what the Company believes is a breakthrough miniature mass spectrometer. Furthermore, Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development.

Astrotech offers satellite and spacecraft pre-launch processing, payload processing and integration, space hardware design and manufacturing, and third party space access acquisition and integration. In addition, the Company offers microgravity commercial drug development, space technology product commercialization for Earth applications, as well as Government Services. Astrotech's new initiative is End-to-End Mission Assurance. This enables the Company to support their satellite customers from conceptual design through orbital insertion and command and control.

This month, 1st Detect, a subsidiary of Astrotech, announced the introduction of their first commercially available product, the MMS-1000(TM) Miniature Mass Spectrometer, designed for use in the research laboratory market. The MMS-1000™ is a high performance laboratory instrument capable of rapid MS/MS detection of trace levels of volatile compounds in approximately five seconds.

In addition, this month 1st Detect announced that the European Patent Office (EPO) issued a key patent for their unique method to drive a mass spectrometer ion trap used for chemical analysis and detection. The patent, entitled "Driving a Mass Spectrometer Ion Trap or Mass Filter," represents a key technological advantage for 1st Detect to optimize the operation of an ion trap using compact and efficient circuitry.

The 1st Detect mini mass spectrometer has broad capabilities. It is a tool for a variety of applications in the research, security, industrial, process flow and healthcare markets. It can detect a wide array of chemicals. These include residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants and pollution products.

Astrotech Corp. (ASTC) closed on Wednesday at $0.76, down 3.67%, on 26,732 volume with 37 trades. The average volume for the last 60 days is 50,890. The 52-week low/high is $0.50/$1.23.

PetroMagdalena Energy Corp. (PMD.V)

Today we are reporting on PetroMagdalena Energy Corp. (PMD.V), here at the QualityStocks Daily Newsletter.

PetroMagdalena Energy Corp. is a Canadian-based oil and gas exploration and production company. The Company has working interests in 19 properties in five basins in Colombia. PetroMagdalena is focusing on increasing and optimizing production from their oil producing assets, while undertaking a comprehensive exploration program on the core oil properties in their portfolio to identify targets and increase reserves. The Company is based in Toronto, Ontario.

PetroMagdalena has working interests in the properties, subject to Agencia Nacional de Hidrocarburos (ANH) approval, in Colombia and more than 1.2 million acres of property. The Company's share of production is currently more than 3,000 barrels of oil equivalent per day (boe/d) before deduction of royalties. They have top quality assets with immediate production growth opportunities located in Colombia's most prolific basins and close to existing oil and gas transportation facilities.

PetroMagdalena Energy has properties in the Llanos Basin, the Catatumbo Basin, the Putumayo Basin, and the Middle Magdalena Basin. More than 1,500 MMBO of recoverable oil has been officially documented in the Llanos Basin.  The Catatumbo Basin, moderately explored, has produced more than 450 MMbbl of oil and 500 Gcf of gas since 1920.

The Putumayo Basin is the northern extension of the Oriente Basin of Ecuador. Covering approximately 104,000 km2, more than 365 MMBO have been found to date in 19 oil fields. The Middle Magdalena basin is along the central reaches of the Magdalena River Valley between the Central and Eastern Cordilleras of the Colombian Andes. Exploration activity to date has led to the discovery of 1,900 MMbbl of oil and 2.5 tcf of gas.

Earlier this month, PetroMagdalena Energy announced the normalization of operations in their Cubiro Block located in the province of Casanares. In previous days, there was an illegal protest where public roads in the province of Casanares were being blocked. This led to a lack of public order in the area. Rig operations were interrupted and trucking operations were halted which affected production schedules. The unlawful blockade was lifted Wednesday evening, March 7, 2012. Operations are returning to normal levels.

PetroMagdalena Energy Corp. (PMD.V) closed on Wednesday at $1.63, up 1.24%, on 81,254 volume. The 52-week low/high is $0.81/$2.38.

Champions Oncology Inc. (CSBR)

Bestotc reported previously on Champions Oncology Inc. (CSBR) and today we report on the Company, here at the QualityStocks Daily Newsletter.

Champions Oncology, Inc. engages in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Company's Tumorgraft™ Technology Platform is a novel approach to personalizing cancer care. Its basis is on the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or Tumorgrafts™, in a manner that preserves the biological characteristics of the original human tumor. Champions Oncology lists on the OTC Bulletin Board. The Company is based in Hackensack, New Jersey. 

Champions Oncology uses the technology in conjunction with related services to offer solutions for two customer groups. One is Personalized Oncology Solutions (POS) in which physicians and patients looking for information help guide the development of personalized treatment plans. The second is Translational Oncology Solutions (TOS) in which pharmaceutical and biotech companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs and increasing the adoption of existing drugs.

The Company's Tumorgraft™ Technology Platform consists of processes, physical tumors and information that they use to personalize the development and use of oncology drugs.  Champions Oncology is building their Tumorgraft™ Technology Platform via the procurement, development and characterization of several Tumorgrafts™ within each of several cancer types.  Tumorgrafts™ are procured through agreements with numerous institutions in the United States and overseas and through their POS business.  The Tumorgrafts™ undergo development and testing through agreement with a U.S.-based preclinical facility.

Champions Oncology provides POS to oncologists through establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options, and to identify and arrange for testing, analysis and study of the patients' cancer tissues, as appropriate.  Furthermore, the Company offers Personalized Tumorgraft™ development, drug studies and genome sequencing as part of their POS. With this, physicians can evaluate the effects of cancer drugs on their patients' tumorgrafts and understand the genetic make-up of their patient's tumor. This enables physicians to better select treatment regimens that may be efficacious to the patient.

In fiscal 2011, Champions Oncology modified their POS business strategy to focus on growing their core technology products. This includes Tumorgraft implants and drug studies. During fiscal 2012, the Company started transitioning the laboratory activities that support the POS and TOS services to their facility in Baltimore, Maryland. The Company expects the transition to be largely complete by the end of the first quarter of fiscal 2013.

Champions Oncology Inc. (CSBR) closed on Wednesday at $0.67, even with yesterday’s close. The average volume for the last 60 days is 2,602. The 52-week low/high is $0.62/$1.25.

graphic

The QualityStocks
Company Corner

graphic
graphic

ProGaming Platforms Corp. (PPTF)

The QualityStocks Daily Newsletter would like to spotlight ProGaming Platforms Corp. (PPTF). Today, ProGaming Platforms Corp. closed trading at $0.29, up 3.94%, on 43,037 volume with 15 trades. The stock’s average daily volume over the past 60 days is 25,359, and its 52-week low/high is $0.115/$0.359.

ProGaming Platforms Corp. (PPTF) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.

Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.

Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.

Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer

ProGaming Platforms Corp. Blog

ProGaming Platforms Corp. News:

ProGaming Platforms Develops Social 3D Flash Game to Showcase Gaming Platform and Capitalize on Online Advertising Opportunities

ProGaming Platforms Issues Letter to Shareholders

ProGaming Platforms Corp. Announces Ten-for-One Forward Stock Split

FluoroPharma Medical, Inc. (FPMI)

The QualityStocks Daily Newsletter would like to spotlight FluoroPharma Medical, Inc. (FPMI). Today, FluoroPharma Medical, Inc. closed trading at $0.80, even for the day on 10,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 24,996, and its 52-week low/high is $0.56/$2.15.

FluoroPharma Medical, Inc. (FPMI) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

FluoroPharma Medical, Inc. Company Blog

FluoroPharma Medical, Inc. News:

FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position

FluoroPharma Medical Announces Phase II Study for CardioPET

FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference

Beacon Enterprise Solutions Group, Inc. (BEAC)

The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.20, up 11.54%, on 243,532 volume with 15 trades. The stock’s average daily volume over the past 60 days is 54,808, and its 52-week low/high is $0.14/$0.54.

Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.

Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.

Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.

Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer

Beacon Enterprise Solutions Group, Inc. Blog

Beacon Enterprise Solutions Group, Inc. News:

Beacon Enterprise Solutions Highlights New Product Offering for Fortune 1000 Clients

Beacon Enterprise Solutions Reports 36% Increase in Blended Project Funnel

Beacon Enterprise Solutions Hires Industry Sales Veteran

GlobalWise Investments (GWIV)

The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.75 off by 2.78%, on 7,100 volume with 14 trades. The stock’s average daily volume over the past 60 days is 3,432, and its 52-week low/high is $1.20/$1.80.

GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer

GlobalWise Investments Company Blog

GlobalWise Investments News:

GlobalWise Announces Channel Sales Partnership With B2B Computer Products

GlobalWise Market Expansion to Capitalize on Industry Trends and Innovations in Mobile Technology

GlobalWise Releases Case Study on Ricart Automotive Group

ProGraming Platforms Corp. (PPTF) Leads the Way in Play-For-Pay

Competitive online gaming, where players form competitive online clubs to challenge each other, is the real growth area of computerized gaming. Add to this the fact that the computer games industry is already bigger than either the U.S. music or movie industry, and the significance of the potential market becomes clear.

The Internet has transported competitive gaming to a new world, where anyone can game with anyone else, no matter where on the planet they live. Virtually every game console and gaming application is now being designed with this global perspective in mind. The next step in the gaming revolution is now at hand – the monetization of competition, allowing players to be financially rewarded, easily, quickly, and dependably, for their playing skill, regardless of the particular game being played.

This is where the ProGaming advanced gaming platform comes in. ProGaming’s proprietary technology handles all of the complex accounting involved in play-for-pay processing, regardless of volume, allowing gamers to focus on the game, without worrying about administrative details. Gamers simply pay a nominal fee any time they want to play, with no need for subscription based fees or memberships. As a result, the market is opened up to a huge new group of players. Fans of any skill game, and any game system, can join or host a paying tournament. Hosting can be provided by ProGaming, or on any third-party server.

In addition, the platform levels the playing field by identifying and ranking players according to previous results, placing them in levels according to their skill. The system is also being designed to detect if a gamer attempts to open new accounts to fool the platform’s ranking system. Most importantly, ProGaming has the only online platform able to efficiently handle the rapidly developing volumes of global traffic.

For more information about the company, visit www.progamingcorp.com

VolitionRX Ltd. (VNRX) to Advance Blood-Based Diagnostics for Cancer

VolitonRX, a life sciences company focused on the development of diagnostic blood tests, is developing its Nucleosomics™ technology to measure and identify the signatures of nucleosomes (a protein component of a chromosome containing a short length of DNA) that are released into the blood as cells die. The company believes its pioneering technology will help detect early stage diseases that are characterized by high cell turnover, such as cancer.

When a cell dies, individual nucleosomes are released into the blood to be recycled. It is well-known that high levels of nucleosomes are released into the blood stream as a result of the cell death associated with certain diseases and that the structure of nucleosomes is altered in the chromosomes of cancer cells. VolitonRX’s technology evaluates the amount and types of nucleosomes present in the blood to provide accurate diagnosis.

VolitionRX is currently in the process of developing a number of Nucleosomics™ tests for different types of nucleosomes and has conducted small pilot studies to investigate whether these nucleosomes are present in the blood of cancer patients and whether cancer nucleosomes are different to nucleosomes from healthy cells. Clearly, the chances of surviving cancer are greatly improved by early detection and diagnosis.

VolitionRX’s Chief Scientific Officer, Jake Micallef, advised that preliminary studies of VolitionRX’s Nucleosomics technology have provided positive data, spurring further development and progression to large-scale clinical studies to support its revolutionary diagnostic blood tests.

“Early stage results from our laboratory have exceeded our expectations, and we hope to see equally positive results in larger scale retrospective clinical studies and prospective clinical studies currently in the pipeline,” he said.

VolitionRX is now focused on validating the results provided by these preliminary studies through large scale clinical studies to ensure development of a blood-based diagnostic for cancer is advanced as quickly as possible. More information on the company and its cutting-edge technology can be found at the following website: www.volitionrx.com

SEFE, Inc. (SEFE) Set to Market Harmony III Commercial-Grade Atmospheric Power Collection and Generation System

SEFE has a remarkable proprietary system that utilizes a weather balloon-based platform and dynamic tethering system to send aloft a conductive line. The collector then harvests static electricity directly from the constantly recharged atmosphere, transforming it into current usable by generators and the existing power grid.

Working with consultants from FAA and the fabrication industry, SEFE has engineered a safe, fully FAA-compliant and affordable solution which can easily be deployed anywhere. The Harmony III is ideal for a variety of industrial, mining, military, and utility needs, promising to curb fossil fuel dependency while immediately contributing to carbon offset.

The components within the system’s architecture are very durable, and because the individual units are networked together remotely via secure encrypted wireless connection, it is very easy to maintain the entire grid of systems simultaneously or perform real-time diagnostics and status checks.

The most important component is the generator which is able to harvest and transform current into a usable format irrespective of the particular site demands. What makes this patented technology even more promising is its versatility and ability to meet future demands.

Just think of it, variations of the Harmony III, whose systems are backed by SEFE patents, could one day replace other forms of energy production; even renewables like wind, solar, and hydro-electric which bear major cost and logistical drawbacks compared to a network of SEFE units.

The global atmospheric electrical circuit is everywhere on earth and peak output occurs at varying altitudes. The SEFE unit is designed to dynamically adjust and find the “sweet spot” for maximum yield and unlike alternative energy is vastly more simple to deploy and connect.

The Harmony III might seem too good to be true but recent testing continues to produce data that not only is wattage available, even at low altitudes, but that the amount available increases sharply with altitude.

Output from the SEFE units is calculated as 1.01B kWh/year, enough to power 140 homes day and night, forever.

The impact of this technology is staggering and the implications should be readily apparent.

PositiveID Corp. (PSID) Receives Nucleic Acids From the CDC Influenza Division to Develop a Diagnostic Assay to Detect H5N1 Avian Flu

PositiveID, an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense industry, announced today that it has received material from the U.S. Centers for Disease Control and Prevention’s (CDC) Influenza Division-National Center for Immunization and Respiratory Diseases to develop a diagnostic assay to detect Influenza A H5N1, also known as avian flu. This assay will provide a test result in less than 30 minutes at the point of care, and is expected to be available for the upcoming flu season for diagnostic and surveillance applications.

The United Nations has urged people to be ready against a possible but major resurgence of the avian flu. According to the CDC, of the few avian influenza viruses that have crossed the species barrier to infect humans, the mutant strain of bird flu has caused the largest number of detected cases of severe disease and death in humans. Human cases of avian influenza A (H5N1) have been reported in Asia, Africa, Europe, Indonesia, Vietnam, the Pacific, and the near East. Slightly more than 60 percent of those who became ill have died.

PositiveID’s assay for avian flu, as well as its other currently available assays, will run on the Company’s patented Dragonfly Rapid MDx platform. Dragonfly was created out of the Company’s M-BAND system, which was developed under contract from the Department of Homeland Security. The H5N1 assay will also be compatible with other commercial platforms.

The Company currently has proven assays for E.coli O157:H7; human papilloma virus (HPV); methicillin-resistant Staphylococcus aureus (MRSA); and a multiplex bio-threat assay that simultaneously tests for six bio-threat organisms on the CDC Category A and B list.

The development of an H5N1 assay is the Company’s most recent push into the clinical diagnostics market, where it will offer faster, less expensive testing methods than those that are commonly used.

William J. Caragol, Chairman and CEO of PositiveID, stated, “Our assay for H5N1, as well as our other clinical diagnostic assays, will be faster and less expensive than the industry standard testing protocol. Furthermore, our microfluidic technology is highly adaptable, which enables us to develop new assays for emerging bio-threats and viruses relatively quickly, which we believe will help us as we enter the clinical diagnostic market.”

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

OTCPicks
(OPHC)

2.

ExclusiveStockAlerts
(IJJP)

3.

SmallCap Network
(STVF)

graphic
By The Numbers Charts
QualitystockTwits

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251